Tag Archive for: Supreme Court

The U.S. Supreme Court, which in 2022 ended its recognition of a constitutional right to abortion, today agreed to hear a bid by President Joe Biden’s administration to preserve broad access to the abortion pill, setting up another major ruling on reproductive rights set to come in a presidential election year.

The Supreme Court is set to hear a challenge by President Joe Biden’s administration to the legality of OxyContin maker Purdue Pharma’s bankruptcy settlement, a deal that if approved would shield its wealthy Sackler family owners from lawsuits over their role in the country’s opioid epidemic.

Mifepristone’s legal saga continues as the U.S. 5th Circuit Court of Appeals ruled for steep restrictions on the drug’s access, though its effectivity is pending the Supreme Court’s review.

The justices paused bankruptcy proceedings concerning Purdue and its affiliates and said they would hold oral arguments in December in the administration’s appeal of a lower court’s ruling upholding the settlement.

The U.S. Department of Justice asked the U.S. Supreme Court to stop Purdue Pharma from proceeding with a bankruptcy settlement that protects its Sackler family owners from lawsuits.

The U.S. Supreme Court unanimously ruled Amgen’s cholesterol drug Repatha patents invalid, ending a protracted legal battle with competitors Sanofi and Regeneron.

While media attention has focused on the availability of abortions, take note: contradictory court decisions about mifepristone broadly threaten the authority of the Food and Drug Administration (FDA) to approve and regulate new medications for any indication.

The U.S. Supreme Court is poised to determine whether the abortion pill mifepristone will continue to be broadly available in the United States as it weighs a bid by Democratic President Joe Biden’s administration to defend the drug in a challenge to its regulatory approval by anti-abortion groups.

President Joe Biden’s administration on Friday asked the U.S. Supreme Court to block limits set by lower courts on the abortion pill mifepristone as the federal government seeks to defend access to the drug in the face of mounting abortion bans and restrictions enacted by Republican-led states.

The U.S. Supreme Court is set to hear a bid by Amgen to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a “blatant attempt” to squeeze competitors out of the market.